On Cancer

Search by keywords:

and/or
Show search filters

Explore by tags:

812 Blog posts found

Prolific Partnership Yields Radiation Therapy Advances

A unique alliance of radiation oncologists and medical physicists at Memorial Sloan Kettering has resulted in key advances in radiation therapy.

Pictured: Micheal Zelefsky

In the Clinic

Treating Prostate Cancer with a Missile-Like Delivery of High-Dose Radiation

We offer men with prostate cancer the most advanced radiation therapy approaches for more-personalized and effective care.

Pictured: Michael Zelefsky

In the News

Memorial Sloan Kettering’s Challenges to Cancer Drug Pricing Featured in New York Magazine Cover Story

Memorial Sloan Kettering experts question the high cost of cancer drugs in a New York Magazine cover story.

Pictured: Leonard Saltz & Peter Bach

Q&A

Too Much Information? Geneticist Mark Robson Discusses Accidental Genetic Findings

As genome sequencing of tumors becomes more routine, it increases the odds that additional disease-related mutations may be discovered by accident, a development that raises profound issues.

Pictured: Mark Robson

Profile

At Work: Cell Biologist Emily Foley

Memorial Sloan Kettering cell biologist Emily Foley discusses her research, which is focused on improving the understanding of cell division.

Pictured: Emily Foley

Event

Robin Roberts Celebrates with Fellow Stem Cell Transplant Recipients

Robin Roberts celebrated with more than 200 fellow stem cell transplant patients at Memorial Sloan Kettering’s annual Stem Cell Transplant Survivors Celebration.

Pictured: Sergio Giralt & Robin Roberts

In the Lab

Immune Cells in the Brain Could be Enlisted to Fight Glioblastoma

Memorial Sloan Kettering researchers say a drug that acts on noncancerous, tumor-infiltrating cells might provide a new treatment option for the most common and aggressive type of brain cancer.

Mouse glioblastoma tumor with phagocytic macrophages

Honor

Former Memorial Sloan Kettering Researcher James Rothman Among Nobel Prize Winners

James Rothman, who receives this year’s Nobel Prize in Physiology or Medicine together with Randy Schekman and Thomas Südhof, conducted more than a decade of his seminal research at Memorial Sloan Kettering.

Pictured: James E. Rothman, Thomas C. Südhof & Randy W. Schekman

Cancer Guide

New Information about Mesothelioma Diagnosis and Treatment at Memorial Sloan Kettering

Memorial Sloan Kettering is recognized worldwide for its treatment of pleural and peritoneal mesothelioma.

Pictured: Lee Krug

In the Community

Reducing Health Disparities in US South Asian Population

Memorial Sloan Kettering leads a first-of-its-kind initiative to reduce cancer and cardiovascular health disparities among South Asian immigrants in the United States.